Cyclobenzaprine is a skeletal muscle relaxant and a central nervous system (CNS) depressant. It is marketed as Flexeril (5 and 10 mg tablets). Both the 5 and 10 milligram tablets are available generically.
It is also prescribed off-label as a sleep-aid.
Use of cyclobenzaprine with an SSRI (Selective Serotonin Reuptake Inhibitor) is not recommended and could lead to unpleasant and possibly damaging interactions. No deaths have been associated with cyclobenzaprine overdose, and permanent damage is almost always related to overactivity of relaxed muscles or contraindications with other drugs.
When used for illicit purposes, the drug is often referred to as "cyclone" with recreational doses ranging from 20 to 80 mg. At these dosages, users report mild to moderate drowsiness and relaxation as the primary effects. Compared with other commonly abused CNS depressants, cyclobenzaprine's effects are considered to be mild, limiting its popularity as a recreational drug.
As a generality, habitual drug users tend to steer clear of anti-depressants, because of the possibility of contraindications with other psychoactive drugs. Cyclobenzaprine, on the other hand, can induce moderate to severe anticholinergic effects at higher doses, as well as benzodiazepine-like sedation and often pleasurable muscle-relaxation. At even higher doses, cyclobenzaprine may cause severe ataxia, and due to excessive muscle-relaxation, and possibly disorienting side effects such as a floating sensation or other imagined movements (usually experienced when at rest.) Side effects such as these are directly related to the favoritism of newer, more mild antidepressant medications over tricyclic antidepressants.
Although purportedly unpleasant, cyclobenzaprine is relatively benign in case of overdose, depending on its toxicity level in the user, and also on the susceptibility of the user to possibly harmful effects of overdose. Note that the susceptibility to these potentially damaging effects is greatly increased when cyclobenzaprine is used in conjunction with other drugs, particularly Central Nervous System Depressants and other antidepressants. Use of cyclobenzaprine with a MAOI (Mono Amine Oxidase Inhibitor) will very possibly result in fatality.
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Cyclobenzaprine".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world